SCHEMBL13857883

SCHEMBL13857883

Sc1csc2cccnc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSMD14 O00487 4/20 0.45
COPS5 Q92905 4/20 0.45
KDM4E B2RXH2 3/20 0.38
LMNA P02545 3/20 0.38
HSP90AA1 P07900 2/20 0.38
MMP2 P08253 2/20 0.38
TSHR P16473 2/20 0.38
GMNN O75496 1/20 0.38
TP53 P04637 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
MAPT P10636 1/20 0.38
MMP9 P14780 1/20 0.38
ALOX15 P16050 1/20 0.38
NFKB1 P19838 1/20 0.38
MMP8 P22894 1/20 0.38
CCR1 P32246 1/20 0.38
THPO P40225 1/20 0.38
MTOR P42345 1/20 0.38
HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL544974 0.77 KDM4E (0.40) PSMD14COPS5KDM4ELMNAHSP90AA1
SCHEMBL31167172 0.75 LIMK1 (0.43) KDM4ELMNAHSP90AA1MMP2TSHR
SCHEMBL358917 0.75 L3MBTL1 (0.43) PSMD14COPS5KDM4ELMNAHSP90AA1
SCHEMBL3970053 0.75 HSP90AA1 (0.40) KDM4ELMNAHSP90AA1MMP2TSHR
SCHEMBL5183987 0.75 LIMK1 (0.43) KDM4ELMNAHSP90AA1MMP2TSHR
SCHEMBL5182523 0.75 LMNA (0.39) PSMD14COPS5KDM4ELMNAHSP90AA1
SCHEMBL9541333 0.75 METAP2 (0.45) KDM4ELMNAHSP90AA1MMP2TSHR
SCHEMBL8114833 0.75 KDM4E (0.40) PSMD14COPS5KDM4ELMNAHSP90AA1
SCHEMBL22430423 0.71 HSP90AA1 (0.35) KDM4ELMNAHSP90AA1MMP2TSHR
SCHEMBL31297691 0.71 CYP17A1 (0.41) KDM4ELMNAHSP90AA1MMP2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140235548-A1 COMPOSITIONS AND METHODS FOR JAMM PROTEIN INHIBITION CLEAVE BIOSCIENCES, INC. (US) 2014-08-21 US claimed
EP-2710119-A1 COMPOSITIONS AND METHODS FOR JAMM PROTEIN INHIBITION Cleave Biosciences, Inc. (US) 2014-03-26 EP claimed
WO-2012158435-A1 COMPOSITIONS AND METHODS FOR JAMM PROTEIN INHIBITION ZHOU HAN-JIE (US) 2012-11-22 WO claimed
CN-112645968-B Fused ring compound containing two boron atoms and two oxygen family atoms and organic electroluminescent device 中国科学院长春应用化学研究所 2022-06-07 CN disclosed
CN-112645968-A Fused ring compound containing two boron atoms and two oxygen family atoms and organic electroluminescent device 中国科学院长春应用化学研究所 2021-04-13 CN disclosed
US-20140235548-A1 COMPOSITIONS AND METHODS FOR JAMM PROTEIN INHIBITION CLEAVE BIOSCIENCES, INC. (US) 2014-08-21 US disclosed
EP-2710119-A1 COMPOSITIONS AND METHODS FOR JAMM PROTEIN INHIBITION Cleave Biosciences, Inc. (US) 2014-03-26 EP disclosed
WO-2012158435-A1 COMPOSITIONS AND METHODS FOR JAMM PROTEIN INHIBITION ZHOU HAN-JIE (US) 2012-11-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140235548-A1 COMPOSITIONS AND METHODS FOR JAMM PROTEIN INHIBITION USP24, USP36, USP39 PSMD14 7/4885COPS5 39/4885KDM4E 2753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.